Efficacy and Safety of rhGH (Jintropin®) in Pediatric Participants With ISS
Clinical trial NCT03635580 · UNKNOWN
Trial details
- NCT number
- NCT03635580
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-11
- Primary completion
- 2021-10-01
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.